INSMED Inc

INSM · Nasdaq · SIC 2834: Pharmaceutical Preparations
202
SEC Filings

Business Summary

PART I Business Overview We are a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. Our commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology & Inflammation, and Neuro & Other Rare. To complement our internal research and development, we also actively evaluate in-licensing and acquisition opportunities for commercial products, p...

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionINSMdiscussed_in_filing Artificial Intelligence
topic_mentionINSMdiscussed_in_filing Cybersecurity
topic_mentionINSMdiscussed_in_filing Trusted Computing
topic_mentionINSMdiscussed_in_filing Blockchain & Crypto
topic_mentionINSMdiscussed_in_filing Regulation
topic_mentionINSMdiscussed_in_filing Healthcare & Bio
topic_mentionINSMdiscussed_in_filing Sovereign & Government
topic_mentionINSMdiscussed_in_filing Artificial Intelligence
topic_mentionINSMdiscussed_in_filing Cybersecurity
topic_mentionINSMdiscussed_in_filing Trusted Computing
topic_mentionINSMdiscussed_in_filing Blockchain & Crypto
topic_mentionINSMdiscussed_in_filing Regulation
topic_mentionINSMdiscussed_in_filing Healthcare & Bio
topic_mentionINSMdiscussed_in_filing Sovereign & Government
topic_mentionINSMdiscussed_in_filing Artificial Intelligence
topic_mentionINSMdiscussed_in_filing Cybersecurity
topic_mentionINSMdiscussed_in_filing Trusted Computing
topic_mentionINSMdiscussed_in_filing Blockchain & Crypto
topic_mentionINSMdiscussed_in_filing Regulation
topic_mentionINSMdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-192025-12-310001104506-26-000009EDGAR91K words
2025-02-202024-12-310001104506-25-000009EDGAR—
2024-02-222023-12-310001104506-24-000008EDGAR—
2023-02-232022-12-310001104506-23-000009EDGAR—
2022-02-172021-12-310001104506-22-000008EDGAR—
2021-02-252020-12-310001104506-21-000005EDGAR—
2020-02-252019-12-310001104506-20-000007EDGAR—
2019-02-222018-12-310001104506-19-000009EDGAR—
2018-02-232017-12-310001104506-18-000002EDGAR—
2017-02-232016-12-310001047469-17-000856EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-302025-09-300001104506-25-000053EDGAR36K words
2025-08-072025-06-300001104506-25-000043EDGAR—
2025-05-082025-03-310001104506-25-000026EDGAR—
2024-10-312024-09-300001104506-24-000033EDGAR—
2024-08-082024-06-300001104506-24-000026EDGAR—
2024-05-092024-03-310001104506-24-000016EDGAR—
2023-10-262023-09-300001104506-23-000025EDGAR—
2023-08-032023-06-300001104506-23-000018EDGAR—
2023-05-042023-03-310001104506-23-000012EDGAR—
2022-10-272022-09-300001104506-22-000023EDGAR—
2022-08-042022-06-300001104506-22-000019EDGAR—
2022-05-052022-03-310001104506-22-000014EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-070001140361-26-013659EDGAR1K words
2026-03-230001140361-26-010651EDGAR—
2026-02-190001140361-26-006116EDGAR—
2026-01-090001140361-26-000778EDGAR—
2025-12-170001140361-25-045836EDGAR—
2025-11-180001140361-25-042598EDGAR—
2025-10-300001140361-25-039789EDGAR—
2025-08-120001140361-25-030537EDGAR—
2025-08-070001140361-25-029343EDGAR—
2025-06-130001140361-25-022375EDGAR—

202 total filings indexed. 170 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001104506
TickerINSM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedVA

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 57967e69c109b0f3558fe032955519ab589e430b061828d8be71ae07c3bc58ad
parent: fb49635be13f3e50bf65866fb9eabd14775f35546c20aedd09d4af6c6e2b86c7
content hash: 1c95553db8d1b0de116f8e0e42944001cf00d53041af4106703082b632396ca2
signed: 2026-04-13T04:45:42.712Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf